Valuation: Getinge AB

Market Cap 6.75TCr 672.22Cr 597.06Cr 558.36Cr 508.81Cr 957.91Cr 65TCr 971.08Cr 2.61TCr 33TCr 2.52TCr 2.47TCr 1,05900Cr P/E 2026 *
21.4x
P/E 2027 * 19.1x
Enterprise Value 7.58TCr 754.23Cr 669.91Cr 626.48Cr 570.89Cr 1.07TCr 73TCr 1.09TCr 2.93TCr 37TCr 2.83TCr 2.77TCr 1,18800Cr EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.97x
Free-Float
79.13%
Yield 2026 *
2.09%
Yield 2027 * 2.28%
1 day+11.16%
1 month+11.16%
3 months+24.69%
6 months+7.62%
Current year+13.12%
Current year 20.05
Extreme 20.05
25
1 year 20.05
Extreme 20.05
25
3 years 15.62
Extreme 15.62
25
5 years 15.62
Extreme 15.62
48.01
10 years 8.75
Extreme 8.75
48.01
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+11.16%-.--% - - 676.67Cr
-1.39%-3.66%-27.05%+1.71% 17TCr
-0.61%-2.96%-9.41%+10.44% 11TCr
-0.95%+1.21%-25.03%-0.30% 11TCr
-0.69%-0.07%-47.78%-11.65% 7.6TCr
+2.98%-0.27%-0.88%+72.57% 5.73TCr
-0.75%-0.45%-6.56%-30.78% 4.88TCr
+3.44%+7.90%+19.12%+59.15% 5.02TCr
-0.12%+1.69%-15.81%+21.14% 4.11TCr
+0.08%-1.08%+30.94%-8.49% 3.26TCr
Average +1.28%-1.46%-9.16%+12.64% 7.7TCr
Weighted average by Cap. -0.15%-2.07%-15.86%+9.74%

Financials

2026 *2027 *
Net sales 3.53TCr 351.13Cr 311.88Cr 291.66Cr 265.78Cr 500.37Cr 34TCr 507.25Cr 1.37TCr 17TCr 1.32TCr 1.29TCr 55TCr 3.73TCr 371.47Cr 329.94Cr 308.55Cr 281.17Cr 529.35Cr 36TCr 536.62Cr 1.44TCr 18TCr 1.39TCr 1.36TCr 59TCr
Net income 317.19Cr 32Cr 28Cr 26Cr 24Cr 45Cr 3.04TCr 46Cr 122.79Cr 1.55TCr 118.51Cr 115.95Cr 4.97TCr 356.04Cr 35Cr 31Cr 29Cr 27Cr 50Cr 3.41TCr 51Cr 137.83Cr 1.74TCr 133.03Cr 130.14Cr 5.58TCr
Net Debt 824.13Cr 82Cr 73Cr 68Cr 62Cr 116.87Cr 7.9TCr 118.48Cr 319.03Cr 4.02TCr 307.93Cr 301.25Cr 13TCr 601.12Cr 60Cr 53Cr 50Cr 45Cr 85Cr 5.76TCr 86Cr 232.7Cr 2.93TCr 224.6Cr 219.73Cr 9.42TCr
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
248.00SEK
Average target price
251.70SEK
Spread / Average Target
+1.49%

Quarterly revenue - Rate of surprise